Skip to main content
. 2021 Sep 30;18(3):1478–1489. doi: 10.1007/s13311-021-01115-5

Fig. 1.

Fig. 1

Antiseizure drug discovery axis. Different preclinical models are compared to each other based on their relevance to humans (X axis), capability to recapitulate epilepsy phenotypes (Y axis), and tractability for screening (Z axis)